EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic Implications

Dalila Incognito, Giuliana Ciappina iD, Claudia Gelsomino, Antonio Picone iD, Pierluigi Consolo, Alessandra Scano, Tindara Franchina, Nicola Maurea iD, Vincenzo Quagliariello iD, Salvatore Berretta, Alessandro Ottaiano iD, Massimiliano Berretta iD

International Journal of Molecular Sciences · 06.10.2025 · 26 (19) · 9710

DOI: 10.3390/ijms26199710 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.10.2025. Verfasst von Dalila Incognito und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, Department of Human Pathology "G. Barresi", School of Specialization in Medical Oncology, University of Messina, 98122 Messina…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Fusobacterium nucleatum, Biomarkers, Tumor, Fusobacterium Infections. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UNIONE EUROPEA Rafforzamento e potenziamento della ricerca biomedica del SSN Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fusobacterium nucleatum (Fn) has been increasingly recognized as a crucial mediator of colorectal cancer (CRC) biology, particularly in microsatellite-stable (MSS) tumors, where immune checkpoint inhibitors (ICIs) have shown limited efficacy. Rather than representing a passive microbial passenger, Fn actively shapes tumor behavior by adhering to epithelial cells, activating oncogenic signaling, and promoting epithelial–mesenchymal transition (EMT). At the same time, it remodels the tumor microenvironment, driving immune suppression through inhibitory receptor engagement, accumulation of myeloid-derived cells, and metabolic reprogramming of tumor-associated macrophages. These mechanisms converge to impair cytotoxic immunity and contribute to both intrinsic and acquired resistance to ICIs. Beyond immune escape, Fn interferes with conventional chemotherapy by sustaining autophagy and blocking ferroptosis, thereby linking microbial colonization to multidrug resistance. Most of these mechanisms derive from preclinical in vitro and in vivo models, where causal relationships can be inferred. In contrast, human data are mainly observational and provide correlative evidence without proving causality. No interventional clinical studies directly targeting Fn have yet been conducted. Its enrichment across the adenoma–carcinoma sequence and consistent detection in both tumor and fecal samples highlight its potential as a biomarker for early detection and patient stratification. Importantly, multidimensional stool assays that integrate microbial, genetic, and epigenetic markers are emerging as promising non-invasive tools for CRC screening. Therapeutic strategies targeting Fn are also under exploration, ranging from antibiotics and bacteriophages to multifunctional nanodrugs, dietary modulation, and natural microbiota-derived products. These approaches may not only reduce microbial burden but also restore immune competence and enhance the efficacy of immunotherapy in MSS CRC. Altogether, current evidence positions Fn at the intersection of microbial dysbiosis, tumor progression, and therapy resistance. A deeper understanding of its pathogenic role may support the integration of microbial profiling into precision oncology frameworks, paving the way for innovative diagnostic and therapeutic strategies in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsFusobacterium nucleatumBiomarkers, TumorFusobacterium InfectionsHumansTumor MicroenvironmentAnimalsEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Fusobacterium nucleatumbiomarkerscolorectal neoplasmdrug resistanceimmune checkpoint inhibitorsimmunotherapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Medical Oncology Unit, Department of Human Pathology "G. Barresi", School of Specialization in Medical Oncology, University of Messina, 98122 Messina, Italy.
  • Section of Experimental Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy.
  • Unit of Digestive Endoscopy, G. Martino University Hospital, University of Messina, 98125 Messina, Italy.
  • Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.
  • Department of Human Pathology of Adulthood and Childhood "G. Barresi", University of Messina, 98122 Messina, Italy.

ORCID-Profile: Giuliana Ciappina, Antonio Picone, Nicola Maurea, Vincenzo Quagliariello, Alessandro Ottaiano, Massimiliano Berretta

Förderung

  • UNIONE EUROPEA Rafforzamento e potenziamento della ricerca biomedica del SSN Next Generation EU

Zitieren

APA

Incognito, D., Ciappina, G., Gelsomino, C., Picone, A., Consolo, P., Scano, A., Franchina, T., Maurea, N., Quagliariello, V., Berretta, S., Ottaiano, A., & Berretta, M. (2025). Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic Implications. International Journal of Molecular Sciences, 26(19), 9710. https://doi.org/10.3390/ijms26199710

Vancouver

Incognito D, Ciappina G, Gelsomino C, Picone A, Consolo P, Scano A, et al. Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic Implications. International Journal of Molecular Sciences. 2025;26(19):9710. doi:10.3390/ijms26199710

BibTeX
@article{Incognito2025,
  author = {Incognito, Dalila and Ciappina, Giuliana and Gelsomino, Claudia and Picone, Antonio and Consolo, Pierluigi and Scano, Alessandra and Franchina, Tindara and Maurea, Nicola and Quagliariello, Vincenzo and Berretta, Salvatore and Ottaiano, Alessandro and Berretta, Massimiliano},
  title = {Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic Implications},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {19},
  pages = {9710},
  doi = {10.3390/ijms26199710}
}
Kostenlos starten →